Tosoni, A. L., and Glass, D. G.: Production of fibrinolytic material from strains of Aspergillus. Canadian patent No. 671647, Oct. 1, 1963.
2.
Tosoni, A. L., and Ives, D. A. J.: Production of high-activity fibrinolytic agents. Canadian patent No. 671648, Oct. 1, 1963, and U.S. patent No. 3140984, July 14, 1964.
3.
Roschlau, W.H.E. : The evaluation in the dog of a proteolytic enzyme derived from Aspergillus oryzae. Canad. J. Physiol. Pharmacol., 42: 109, 1964.
4.
Roschlau, W.H.E. : Natural protease resistance to CA-7 (fibrinolytic enzyme from Aspergillus oryzae) in the dog. Canad. J. Physiol. Pharmacol., 43: 741, 1965.
5.
Roschlau, W.H.E. , and Tosoni, A.L.: Thrombolytic therapy with CA-7 (fibrinolytic enzyme from Aspergillus oryzae) in the dog. Canad. J. PhysiolPharmacol., 43: 731, 1965.
6.
Bergkvist, R. : The proteolytic enzymes of Aspergillus oryzae. IV. On the inhibition of the enzymes by serum. Acta chem. scandinav.,17: 2239, 1963.
7.
Bergkvist, R. , and Svärd, P.O.: Studies on the thrombolytic activity of a protease from Aspergillus oryzae. Acta physiol. scandinav.,60: 363, 1964.
8.
Stefanini, M. , and Karaca, M.: Natural inhibitors of fungal protease (Aspergillin O). Ann. New YorkAcad. Sc.103: 803,1963.
9.
Monkhouse, F.C. , Daramola, F., and Gillespie, R.J.: The action of a proteolytic enzyme from Aspergillus oryzae on components of the blood clotting system. Canad. J. Physiol. Pharmacol., 42: 377, 1964.
10.
Mazel, M.S. , Bolton, H.E., Stern, J.R., Riera, R., and Cabral, H.: Coronary arterial and other intravascular thromboses treated with fibrinolysin. Angiology, 14: 88, 1963.
11.
McNicol, G.P. , Reid, W., Bain, W.H., and Douglas, A.S.: Treatment of peripheral arterial occlusion by streptokinase perfusion. Brit. M. J.,1: 1508, 1963.
12.
McNicol, G.P. , and Douglas, A.S.: Treatment of peripheral vascular occlusion by streptokinase perfusion. Scand. J. Clin. Lab. Invest., 16: Supp. 78, 23, 1964.
13.
Verstraete, M., Amery, A., and Vermylen, J.: Feasibility of adequate thrombolytic therapy with streptokinase in peripheral arterial occlusions. Brit. M. J.1: 1499, 1963.
14.
Atkin, N., Nitzberg, S., and Dorsey, J.: Lysis of intracerebral thromboembolism with fibrinolysin. Angiology, 15: 436, 1964.
15.
Dyer, A.E., and Kadar, D.: Fibrin suspension assay for fibrinolytic activity. Blood, 23: 729, 1964.
16.
Roschlau, W.H.E. , and Painter, R.H.: Human fibrinolysin with and without urokinase: its effect on experimental arterial thrombi in dogs. Canad. J. Biochem. Physiol., 40: 1819, 1962.
17.
Cox, E.F., Flotte, C.T., and Buxton, R.W.: Dextran in the treatment of thrombophlebitis. Surgery, 57: 225, 1965.
18.
Sawyer, R.B. , Moncrief, J.A., and Canizaro , P.C.: Dextran therapy in thrombophlebitis. J. A. M. A., 191: 740, 1965 .